|
|
||||||||
and Lipopolysaccharide Stimulation1

*
Department of Oral Biology, University of Nebraska Medical Center, and
School of Biological Sciences, University of Nebraska, Lincoln, NE 68583
IL-12, pivotal to the development of Th1 cells and formed by
association of p35 and p40 subunits, is made by macrophages and the
macrophage cell line RAW264.7. In this study, the promoter for
p35 was cloned and analyzed. The murine IL-12
p35 gene has promoters upstream from each of the first
two exons. The exon 1 and exon 2 promoters, cloned into a reporter
vector, were responsive to LPS or IFN-
/CD40 ligation in transfected
RAW264.7 cells. The exon 2 promoter containing bp -809 to +1 has
significant homology to the human p35 promoter. Thus, deletion analysis
was performed to determine the regions required for responsiveness to
LPS, CD40, and/or IFN-
. Base pairs -809 to -740 influenced
responsiveness to LPS. In contrast, bp -740to -444 and bp -122 to
-100 were required for responses to IFN-
, IFN-
/LPS, or
IFN-
/CD40 ligation. Removal of bp -444 to -392 increased the
response of the exon 2 promoter to each stimulant. IFN regulatory
factor (IRF)-1 is involved in the activity of this promoter at
bp -108 to -103 because levels of nuclear IRF-1 correlated with exon
2 promoter activity in response to IFN-
and IRF-1 overexpression
stimulated and enhanced exon 2 promoter activity. Also, site or
deletion mutation of the IRF-1 element at bp -108 to -103 reduced the
responsiveness of the promoter and IRF-1 bound to an oligonucleotide
containing bp -108 to -103. The data suggest that the
response of the p35 promoter to IFN-
requires a distinct IRF-1
positive regulatory element at bp -108 to
-103.
This article has been cited by other articles:
![]() |
A. Jayakumar, M. J. Donovan, V. Tripathi, M. Ramalho-Ortigao, and M. A. McDowell Leishmania major Infection Activates NF-{kappa}B and Interferon Regulatory Factors 1 and 8 in Human Dendritic Cells Infect. Immun., May 1, 2008; 76(5): 2138 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Polumuri, V. Y. Toshchakov, and S. N. Vogel Role of Phosphatidylinositol-3 Kinase in Transcriptional Regulation of TLR-Induced IL-12 and IL-10 by Fc{gamma} Receptor Ligation in Murine Macrophages J. Immunol., July 1, 2007; 179(1): 236 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakano, C. Nishiyama, S. Kanada, Y. Niwa, N. Shimokawa, H. Ushio, M. Nishiyama, K. Okumura, and H. Ogawa Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections Blood, June 1, 2007; 109(11): 4846 - 4855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, Z. Xiang, and X. Ma Role of IFN Regulatory Factor-1 and IL-12 in Immunological Resistance to Pathogenesis of N-Methyl-N-Nitrosourea-Induced T Lymphoma J. Immunol., July 15, 2004; 173(2): 1184 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, S. Cao, L. M. Herman, and X. Ma Differential Regulation of Interleukin (IL)-12 p35 and p40 Gene Expression and Interferon (IFN)-{gamma}-primed IL-12 Production by IFN Regulatory Factor 1 J. Exp. Med., October 20, 2003; 198(8): 1265 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goriely, D. Demonte, S. Nizet, D. De Wit, F. Willems, M. Goldman, and C. Van Lint Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites Blood, June 15, 2003; 101(12): 4894 - 4902. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cuesta, C. A. Salkowski, K. E. Thomas, and S. N. Vogel Regulation of Lipopolysaccharide Sensitivity by IFN Regulatory Factor-2 J. Immunol., June 1, 2003; 170(11): 5739 - 5747. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mirani, I. Elenkov, S. Volpi, N. Hiroi, G. P. Chrousos, and T. Kino HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection J. Immunol., December 1, 2002; 169(11): 6361 - 6368. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |